Article
Haptoglobin Genotype and Vitamin E Versus Placebo for the Treatment of Nondiabetic Patients with Nonalcoholic Steatohepatitis in China: A Multicenter, Randomized, Placebo-Controlled Trial Design.
Advances in therapy - 1 Feb 2018
Zang Shufei, Chen Jin, Song Yu, Bai Lang, Chen Jinjun, Chi Xiaoling, He Fangping, Sheng Huiping, Wang Jing, Xie Shilong, Xie Wen, Yang Yongfeng, Zhang Jing, Zheng Minghua, Zou Zhengsheng, Wang Bingyuan, Shi Junping
Abstract excerpt
INTRODUCTION: Vitamin E is one of the most promising agents for nonalcoholic steatohepatitis (NASH) treatment, and its drug responsiveness may be closely associated with haptoglobin (Hp) genotype. However, its efficacy and safety remain unknown in China. This clinical trial of vitamin E versus placebo for the treatment of nondiabetic patients with nonalcoholic steatohepatitis (VENS) is conducted to evaluate (a)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.